Today’s AI Top Pick: BIRK
8/6/2026 · Highly Shorted Oversold screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live BIRK price forecast →
Birkenstock is the cleanest setup on the board today: it is the rare screen-passer that combines real, high-quality fundamentals with a fully aligned multi-timeframe forecast and supportive news flow. Fundamentally, BIRK is not a broken story — PE 16.86, fwdPE 13.33, PEG 0.84, ROE 12.94%, operating margin 24.51%, gross margin 53.86%, profit margin 16.26%, sales YoY +20.35%, debt/equity 0.47, analyst recom 1.62, targetUpside 42.3%. Fundamental_score 7.5 is one of the highest here, and unlike TOYO (thin instOwn 1.64%) or BKV (only two timeframes available), the picture is broadly institutional (instOwn 42.6%) and durable. The tape confirms in every window. 1h fc_mid +7.67%, 4h fc_mid +11.71%, 1d fc_mid +13.44%, 1wk fc_mid +15.2% with 1wk fc_long +21.11% — no single-bar outlier, no timeframe pointing down. bullish_prob = 1.0 and near_term_bullish = 0.8. Critically, we are NOT chasing: position_in_21bar_range is 2.81% (1h), 1.33% (4h), 0.00% (1d), 35.82% (1wk), with drawdowns of −6% to −23% off the 21-bar high. RSI 31.99 puts it inside the oversold zone but not distressed like KPTI (16.31) or CAPR (12.91), where the drop reflects genuine bad news. News flow is a tailwind, not a landmine. On 8/4 UBS reiterated Buy (PT $76) and JP Morgan reiterated Overweight, raising PT to $58 — both well above the current $37.48. The 7/29 U.S. retail expansion story (Boulder, West Palm Beach) supports the +20% sales-growth narrative. Compare that to ADTN (Zacks Strong Sell 8/5, two PT cuts same day), SEDG ("Why SolarEdge Stock Crashed After Earnings"), KPTI (trial failure + downgrade), CAPR (regulatory setback + downgrade), or WING (Q2 challenges + already pinned to top of 1h range at 100%) — each of those has a headline that materially undercuts the technical setup. TODAY is the right entry because BIRK is sitting on the daily 21-bar low (pos 0.00%) after a −17.3% pullback while every forward horizon models a bounce, analysts are raising/holding targets into weakness, and there is no negative catalyst to fade. Waiting for confirmation means paying up into JP Morgan's $58 / UBS's $76 target zone; buying here gives asymmetric R/R with a well-defined invalidation level.
- Consumer Cyclical exposure — perfYear −24.6% and perfYtd −8.36% show the trend is still down; a broader consumer/luxury slowdown could invalidate the bounce
- Short float 20.24% cuts both ways — a squeeze helps, but continued shorting pressure into any weak print can extend the drawdown past the −17.6% daily DD
- Valuation is reasonable but not cheap (PS 2.73) for a footwear name if salesYoY decelerates from the current 20.35%
- Recent analyst action was mixed on price targets (UBS LOWERED PT to $76, though maintained Buy) — sell-side is trimming expectations even while staying constructive
- 1h fc_short is −0.02% and 4h recent_21bar_pct is −9.34%, so near-term chop is likely before the mid/long forecast plays out
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | BIRK | BUY NOW | 8.6 | Fund_score 7.5 + all-four-timeframe bullish alignment (+7.7/+11.7/+13.4/+15.2%) at 0% of daily range with UBS/JPM reiterating Buy — cleanest setup on the board. |
| 2 | BKV | BUY NOW | 8.0 | Highest fundamental_score (8.0) with PE 6.96, ROE 15.9%, profit margin 27.9% and 4h fc_mid +19%; docked slightly for only 2 timeframes. |
| 3 | TOYO | BUY PULLBACK | 6.8 | PEG 0.03, ROE 46.5%, salesYoY 141% and near_term 1.0, but 1wk forecast weak and model's own expected return is negative — retail-heavy float. |
| 4 | PHAT | BUY PULLBACK | 6.4 | Guggenheim/HCW reiterate Buy, salesYoY +110%, all timeframes green (4h fc_mid +55.9%, 1d +42.1%), but still unprofitable (−41.3% margin). |
| 5 | STAA | BUY PULLBACK | 6.2 | Zacks upgrade to Strong Buy 8/5 + permanent CEO appointed; gross margin 75.1% but 1d fc_mid only +6.2% and near_term 0.6. |
| 6 | WING | BUY PULLBACK | 6.0 | Strong fundamentals (profit 16.2%, gross 82.6%, recom 1.48) and 1d fc_mid +79.6%, but pinned at 100% of 1h range — don't chase intraday. |
| 7 | ADTN | BUY PULLBACK | 5.8 | PEG 0.23, epsNextY +94% and 4h fc_short +58.6%, but Zacks Strong Sell 8/5 and two PT cuts the same day are a landmine. |
| 8 | MNRO | WAIT | 5.4 | Near_term 1.0 and 1wk fc_long +49%, but Stephens cut PT to $17, PE 65 with margin 0.59% — fundamentals thin. |
| 9 | VERA | WAIT | 5.0 | 4h/1d forecasts positive, TRUTAKNA FDA approval catalyst, but 1wk fc_long −11.2% and no earnings yet. |
| 10 | FIP | WAIT | 4.8 | Recom 1.0 and 4h fc_mid +50%, but 8/6 Q2 loss miss and profit margin −88% with debtEq 3.96. |
| 11 | COLM | WAIT | 4.6 | Profitable and reasonably valued (PE 14.8), Q2 tariff-recovery narrative, but forecast magnitudes tiny (1d fc_mid +4.5%). |
| 12 | SEDG | WAIT | 4.2 | Just crashed post-earnings 8/5, near_term 0.8 but 1d/1wk forecasts flat-to-negative and recom 3.37. |
| 13 | JBGS | WAIT | 4.0 | All timeframes green (1d fc_mid +38%) but recom 5.0 (sell), operMargin −1.53%, debtEq 2.26. |
| 14 | METC | WAIT | 3.9 | 4h fc_long +101% but fwdPE 110, gross margin 1.3%, and coking coal fundamentals deteriorating. |
| 15 | SPRY | WAIT | 3.6 | Near_term 1.0 with big 1d fc_long +102%, but new CEO transition, opMargin −204%, shortFloat 35%. |
| 16 | BIRD | AVOID | 3.4 | 1d fc_mid +137% but 1wk fc_short/mid/long all around −40% — classic outlier trap; ROE −153.6%, marketCap $20M. |
| 17 | DVLT | AVOID | 3.2 | 1wk forecast of +78,615% is a nonsensical outlier; opMargin −129%, near_term 0.0. |
| 18 | BTCT | WAIT | 3.0 | Micro-cap ($5M) with 1wk fc_short +662% but private placement dilution 7/9 and no real fundamentals. |
| 19 | AESI | WAIT | 2.8 | Kodiak AI partnership expansion is a positive, but RBC cut PT, fund_score −3, gross margin 4.2%, near_term 0.2. |
| 20 | TYRA | AVOID | 2.6 | 1d/1wk forecasts negative, bullish_prob 0.4, Q2 EPS miss 8/4. |
| 21 | LESL | AVOID | 2.4 | 4h fc_long −11%, marketCap $12M, perfYear −80%; extreme distressed micro-cap. |
| 22 | HTZ | AVOID | 2.3 | 8/6 headline: 'index cuts and lawsuit hit'; ROE −567%, forecasts inflated but news is a landmine. |
| 23 | MBRX | AVOID | 2.2 | $2M market cap after −88% YTD; trial data mixed and forecasts are outlier noise. |
| 24 | GLUE | AVOID | 2.0 | bullish_prob 0, 1wk fc_long −47%, PS 30.7 with opMargin −345%. |
| 25 | KPTI | AVOID | 1.9 | 7/31 XPORT-EC-042 trial FAILED primary endpoint + HCW downgrade to Neutral — thesis broken. |
| 26 | CAPR | AVOID | 1.7 | DMD regulatory setback + Piper downgrade 7/30–31; RSI 12.9 reflects real damage, not opportunity. |
| 27 | NRXP | AVOID | 1.5 | bullish_prob 0.2, ALL forecasts negative across every timeframe, PS 55.96, opMargin −749%. |
| 28 | GDC | AVOID | 1.2 | 1wk fc all −100%; perfYear −99.79% — terminal setup, ignore the outlier 4h/1d forecast noise. |
| 29 | SNBR | AVOID | 0.9 | $2.88M market cap, perfYTD −98.5%, forecasts are 5000%+ outliers on a broken chart. |
| 30 | ADTX | AVOID | 0.5 | perfYTD −100%, price ~$0, forecasts in the millions of percent — data artifact, not a trade. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord